Discounted Cash Flow
Elanco Animal Health Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $2.9b | $-310.7m | $-88.6m | -10.8% | $-1.06 |
| 2018 | $3.1b (6.2%) | $86.5m (127.8%) | $-85.5m (3.5%) | 2.8% (126.2%) | $0.28 (126.0%) |
| 2019 | $3.1b (0.1%) | $67.9m (-21.5%) | $-153.1m (-79.1%) | 2.2% (-21.6%) | $0.18 (-33.3%) |
| 2020 | $3.3b (6.6%) | $-560.1m (-924.9%) | $-114.9m (25.0%) | -17.1% (-873.9%) | $-1.27 (-789.6%) |
| 2021 | $4.8b (45.6%) | $-472.0m (15.7%) | $-120.0m (-4.4%) | -9.9% (42.1%) | $-0.97 (23.7%) |
| 2022 | $4.4b (-7.4%) | $-78.0m (83.5%) | $-139.0m (-15.8%) | -1.8% (82.1%) | $-0.16 (83.5%) |
| 2023 | $4.4b (0.1%) | $-1.2b (-1478.2%) | $-131.0m (5.8%) | -27.9% (-1476.1%) | $-2.50 (-1465.4%) |
| 2024 | $4.4b (0.5%) | $338.0m (127.5%) | $-144.0m (-9.9%) | 7.6% (127.3%) | $0.68 (127.4%) |
| 2025 | $4.7b (6.2%) | $-232.0m (-168.6%) | $-282.0m (-95.8%) | -4.9% (-164.6%) | $-0.47 (-168.3%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.